USA Rare Earth Is Breaking Ground on Its $1.2 Billion South Carolina Facility. Is It Time to Buy the Critical Minerals Stock?

USA Rare Earth broke ground on a $1.2 billion, 800,000-square-foot South Carolina magnet facility expected to add 6,400 metric tons per year of magnet capacity and 5,000 tons of strip-cast capacity. Together with its Oklahoma expansion, the company targets 10,000 metric tons annually of both products by 2029, supporting a mine-to-magnet supply chain intended to reduce U.S. dependence on China. The company also acquired Serra Verde for about $2.8 billion and Texas Mineral Resources, but substantial capital needs and CHIPS Act-linked equity dilution leave the investment case high risk.

Analysis

USAR’s equity value is best viewed as a long-dated project-finance call option, not a near-term rare-earth price lever. The key underwriting variable is funding cost: a multi-year buildout alongside mine development and a major acquisition creates a high probability of incremental equity issuance, cost overruns, or refinancing before meaningful free cash flow. A domestic supply-chain premium is real in defense procurement, but customers will require qualification cycles and reliability data; announced capacity does not translate directly into contracted EBITDA.

The more actionable second-order beneficiary is MP Materials (MP), which already has commercial-scale U.S. operations and can monetize customer urgency earlier through offtake, processing, and magnet supply agreements. USAR’s eventual entry could cap domestic magnet margins after 2029, but in the next 12-24 months it reinforces the strategic-value narrative for established Western supply rather than creating incremental supply. Lynas Rare Earths (LYC.AX) also benefits as non-China buyers diversify, though its earnings remain more directly exposed to NdPr pricing.

The contrarian issue is that government support can lower project risk while simultaneously subordinating common equity economics: grants, loans, warrants, and mandated equity commitments can preserve the asset while diluting shareholders. Verify the alleged funding terms, acquisition consideration, pro forma debt, cash balance, and binding customer offtakes before assigning value to planned capacity. The thesis improves only if USAR demonstrates construction milestones on budget, secures take-or-pay contracts, and funds the remaining capex without materially increasing the share count.

Near term, geopolitical rhetoric or new Chinese export restrictions could drive a momentum move in USAR and the rare-earth complex within days. Over 1-3 months, financing disclosures and quarterly cash burn matter more than commodity headlines; over 6-18 months, project execution and heavy-rare-earth recoveries determine whether the company earns a strategic multiple. A sustained decline in NdPr prices, delayed permits, capex inflation above budget, or a large discounted equity raise would falsify the bullish case.

Key Decisions for Investors

• No core USAR long until independently verified financing and pro forma capitalization are available; treat any position as a small event-driven allocation with a 6-12 month horizon, not a strategic holding.
• Prefer long MP over USAR for 12-18 months: MP has nearer-term operating leverage to domestic supply-chain localization while USAR carries construction, integration, and dilution risk. Reassess if MP’s production/qualification milestones slip or USAR secures binding offtakes that cover a material portion of planned output.
• For a relative-value expression, consider long MP / short USAR only after a USAR financing or share-issuance event, sized modestly given policy-driven short-squeeze risk. Cover the short if USAR discloses fully funded construction, fixed-price EPC protections, and credible take-or-pay contracts.
• Set an alert for USAR quarterly cash burn, net debt, share count, and capex guidance. A meaningful raise at a discount or capex revision higher would be a downside catalyst; conversely, a non-dilutive government award with disclosed terms is the key event that would invalidate the dilution thesis.